ULBI Ultralife

Ultralife Corporation to Report Second Quarter Results on August 7, 2025

Ultralife Corporation to Report Second Quarter Results on August 7, 2025

NEWARK, N.Y., July 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2025 before the market opens on Thursday, August 7, 2025.

Ultralife’s Management will also host an investor conference call and simultaneous webcast at Noon ET on August 7, 2025. Please see the call-in procedures which follow below.

NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE:

To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: . This will eliminate the need to speak with an operator. Once registered, dial-in information will be provided along with a personal identification number. Should you register early and misplace your details, you can simply click back on this same link at any time to register and view this information again.

A live webcast of the conference call will be available to investors in the Events & Presentations Section of the Company’s website at . For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit .

Company Contact:Investor Relations Contact:
Ultralife CorporationAlliance Advisors IR
Philip A. FainJody Burfening/Alex Villalta
(315) 210-6110(212) 838-3777
 
  


EN
29/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ultralife

Ultralife Corp: 1 director

A director at Ultralife Corp bought 53,900 shares at 4.971USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Ultralife Corporation Reports Third Quarter Results

Ultralife Corporation Reports Third Quarter Results NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results: Sales of $43.4 million increased 21.5% from $35.7 million for the third quarter of 2024; excluding Electrochem, sales of $36.6 million increased 2.5%Gross profit of $9.6 million, or 22.2% of revenue, compared to $8.7 million, or 24.3% of revenue, for the third quarter of 2024Operating loss of $1.0 million, reflecting one-time non-recurring costs of $1.1...

 PRESS RELEASE

Ultralife Corporation to Report Third Quarter Results on November 18, ...

Ultralife Corporation to Report Third Quarter Results on November 18, 2025 NEWARK, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on November 18, 2025.   Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conferenc...

 PRESS RELEASE

Ultralife Corporation Files Form 12b-25 Notification of Late Filing

Ultralife Corporation Files Form 12b-25 Notification of Late Filing NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025. As previously disclosed, on October 31, 2024, Ultralife completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) from Integer Holdings Corporation (“Integer”). During the third quarter of 2025, th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch